Sign up Australia
Proactive Investors - Run By Investors For Investors

Small-Cap Snapshot: Medical device company Nevro is on the rise after a court rules in its favor

The company has been involved in a patent infringement litigation suit with Boston Scientific
Court imagery
Nevros' methods were found to be patent eligible but Boston Scientific was not found guilty of infringement


ResTORbio Inc (NASDAQ:TORC) was a top gainer following positive trial results. In a Phase 2b trial of its drug RTB101, a treatment for respiratory tract infections, showed a reduction in the percentage of patients with one or more RTIs. The company went public in January and the lock-up period will soon expire, allowing shareholders to sell shares. Shares skyrocketed up more than 65% to US$15 in Wednesday afternoon trading.

Nevro Corp (NYSE:NVRO) shares are up double-digits after a court ruled in favor of the company regarding its patent infringement litigation with Boston Scientific Corporation (NYSE:BSX). As per the ruling, six method claims in three of its patents were found to be patent eligible. However, the court did not find that Boston Scientific to be infringing the six method claims. Nevro plans to appeal a portion of the ruling. Shares of the medical device company jumped nearly 40% to US$60.29.


Helios and Matheson Analytics Inc (NASDAQ:HMNY) shares are sinking following a 1-to-250 reverse stock split. The big data company implemented the split to prevent the company from being delisted from the Nasdaq. The company the parent of movie subscription service MoviePass. Shares were down around 40% to US$12.96.

Tupperware Brands Corporation (NYSE:TUP) reported disappointing second-quarter results. The storage company saw lower-than-expected sales due to a slip in demand. Ultimately, the container company cut its full-year forecast. Shares of the Florida-based company were down more than 15% to US$34.30.

The Russell 2000 small-cap index was down slightly in Wednesday afternoon trading.

View full TORC profile View Profile

resTORbio Inc Timeline

Related Articles

Workers at CERN
August 02 2018
Private banks and healthcare groups took part in the share placing
May 30 2018
The latest fundraiser underscores the fact the life sciences business is well supported in the City
November 29 2017
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use